| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.1B | $0.6B | $0.8B | $1.1B | $1.0B | $1.2B | $2.3B | $2.7B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.1B | $0.1B | $0.2B | $-0.3B | $-0.3B | $-2.7B | $-1.0B | $-0.5B |
| EPS (Basic) | $0.46 | $0.07 | $0.78 | $-2.47 | $-0.78 | $-5.81 | $-2.41 | $-1.28 |
| EPS (Diluted) | $0.46 | $0.07 | $0.77 | $-2.47 | $-0.78 | $-5.81 | $-2.41 | $-1.28 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.4B | $3.5B | $3.6B | $11.0B | $14.2B | $20.2B | $19.8B | $22.2B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.4B | $0.3B | $0.3B | $0.9B | $1.6B | $0.7B | $1.2B | $0.5B |
| Total Liabilities | $1.0B | $1.0B | $1.1B | $6.5B | $8.9B | $12.9B | $10.9B | $11.1B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $2.1B | $2.0B | $1.8B | $1.7B | $2.1B | $2.5B | $5.2B | $7.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.1B | $0.2B | $0.3B | $0.2B | $0.1B | $0.2B | $0.5B |
| Investing Cash Flow | $-0.1B | $-0.0B | $-1.0B | $-1.9B | $0.1B | $-1.9B | $4.2B | $-0.3B |
| Capital Expenditures | $0.0B | $0.0B | — | — | — | — | — | — |
| Financing Cash Flow | $-0.0B | $-0.1B | $0.1B | $0.9B | $0.4B | $1.4B | $-3.8B | $-0.8B |